Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Prizes

The 2017 iCMLf Goldman Prize is awarded toTimothy Hughes

Professor Timothy P. Hughes

The iCMLf Directors and a panel of previous prizewinners have named Professor Tim Hughes as the 2017 recipient of the iCMLf Goldman Prize. Named in honour of Professor John Goldman, the Goldman Prize recognises lifetime contributions to the management of patients with CML.

Professor Hughes is an internationally recognised expert in the biology and treatment of CML. He led the establishment of the molecular response criteria that are now used worldwide to measure response in CML. He has also been Principal Investigator for many CML trials and has been on the management committee for many of the key global CML trials using kinase inhibitors.

His contributions to the clinical research and the management of CML include demonstrating the importance of molecular monitoring in CML patients receiving kinase inhibitor therapy, showing the clinical relevance of mutation monitoring in the resistance setting and promoting treatment-free remission as the new goal of CML management.

Dr. Hughes is Cancer Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI), Beat Cancer Professor at the University of Adelaide and Consultant Haematologist at the Royal Adelaide Hospital

His current research interests are in molecular monitoring for CML, clinical resistance to targeted therapies and the development of assays to predict response and resistance. He has published over 250 articles with over 38,000 citations in peer-reviewed journals.

In 2009 Tim Hughes co-founded the International CML Foundation together with John Goldman and Jorge Cortes. After shaping the iCMLf’s strategy and programs for years as member of the Board of Directors Tim was appointed as iCMLf Chairman in 2014.

“I am really delighted to receive this award. It was John Goldman who gave me the passion to focus all my clinical and research efforts onto CML, so this is very fitting. I hope he would approve!” (Professor Timothy P. Hughes)


Learn more about Timothy P. Hughes here